In an era of fiscal restraint, it is important to evaluate the resources required to diagnose and treat serious illnesses.
As breast cancer is the major malignancy affecting Canadian women, Statistics Canada has analysed the resources required to manage this disease in Canada, and the associated costs.
Here we report the cost of initial diagnosis and treatment of nonmetastatic breast cancer, including adjuvant therapies.
Treatment algorithms for Stages I, II, and III of the disease were derived by age group (<50 or >= 50 years old), principally from Canadian cancer registry data, supplemented, where necessary, by the results of surveys of Canadian oncologists.
Data were obtained on breast cancer incidence by age, diagnostic work-up, stage at diagnosis, initial treatment, follow-up practice, duration of hospitalization and direct care costs.
The direct health care costs associated with'standard'diagnostic and therapeutic approaches were calculated for a cohort of 17 700 Canadian women diagnosed in 1995.
Early stage (Stages I and II) breast cancer represented 87% of all incident cases, with 77% of cases occurring in women >= 50 years.
Variations were noted in the rate of partial vs total mastectomy, according to stage and age group.
Direct costs for diagnosis and initial treatment ranged from $8014 for Stage II women >= 50 years old, to $10 897 for Stage III women<50 years old. (...)
Mots-clés Pascal : Tumeur maligne, Glande mammaire, Canada, Amérique du Nord, Amérique, Diagnostic, Traitement, Coût global, Modèle simulation, Evaluation, Homme, Glande mammaire pathologie
Mots-clés Pascal anglais : Malignant tumor, Mammary gland, Canada, North America, America, Diagnosis, Treatment, Life cycle cost, Simulation model, Evaluation, Human, Mammary gland diseases
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 99-0243045
Code Inist : 002B20E02. Création : 16/11/1999.